531 results on '"Shiina S"'
Search Results
2. Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation
3. Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses
4. Color vision evolution in egg-laying mammals: insights from visual photoreceptors and daily activities of Australian echidnas
5. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH
6. Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary ballon
7. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
8. Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors
9. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique
10. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract
11. Roles of Ca2+ and protein kinase C in regulation of prostaglandin E2 release by cultured rabbit gastric epithelial cells
12. Serum endostatin levels in patients with hepatocellular carcinoma
13. Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma
14. Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study.
15. Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma.
16. Abstracts of selected papers presented at the 74th general meeting of the Japanese Society of Gastroenterology
17. EQUILIBRIUM AND STABILITY OF THETA-PINCH PLASMA IN MODIFIED TOROIDAL MULTIPLE MIRROR FIELD
18. Theoretical studies of parallel current in the presence of fluctuations
19. P574 HIGH SENSITIVITY C-REACTIVE PROTEIN IS AN INDEPENDENT PREDICTOR FOR RECURRENCE AND SURVIVAL AFTER CURATIVE TREATMENT AMONG PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA IN EARLY STAGE
20. [Management of complications associated with local ablation therapy for hepatocellular carcinoma]
21. [Percutaneous tumor ablation therapy for the advanced stage of HCC]
22. New approach to transport improvement in a helical magnetic axis system by introduction of effective toroidal curvature
23. Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma.
24. [Percutaneous ethanol injection therapy for small hepatocellular carcinoma]
25. 1028 CHRONOLOGICAL CHANGES IN CHARACTERISTICS OF HCV-RELATED HEPATOCELLULAR CARCINOMA IN JAPAN: OLD AGE MAY FACILITATE CANCER DEVELOPMENT IN LESS ADVANCED FIBROSIS
26. 835 RISK FACTORS FOR HEPATOCARCINOGENESIS IN NON-VIRAL, NON-ALCOHOLIC HEPATITIS AND CIRRHOSIS
27. 1013 IMPACT OF NEWLY DEVELOPED HIGH-SENSITIVE (I-FETOPROTEIN-L3 FRACTION ASSAY ON THE DIAGNOSIS AND TREATMENT EVALUATION OF HEPATOCELLULAR CARCINOMA
28. ChemInform Abstract: Stereoselective Reactions. Part 19. Asymmetric Dihydroxylation of Olefins by Employing Osmium Tetroxide-Chiral Amine Complexes.
29. ChemInform Abstract: C-2 Epimerization of Aldoses by Calcium Ion in Basic Solutions. A Simple System to Transform D-Glucose and D-Xylose into D-Mannose and D- Lyxose.
30. Ten-year expericence of percutaneous radiofrequency ablation for hepatocelluar carcinoma.
31. 407 PROSPECTIVE RISK ASSESSMENT FOR HEPATOCELLULAR CARCINOMA RECURRENCE BY TRANSIENT ELASTOGRAPHY AFTER CURATIVE RADIOFREQUENCY ABLATION
32. 601 CLINICAL FEATURES OF ADVANCED HEPATOCELLULAR CARCINOMA WITH EXTRAHEPATIC METASTASIS
33. 409 PROSPECTIVE RISK ASSESSMENT FOR HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS C PATIENTS BY TRANSIENT ELASTOGRAPHY
34. 130 CONSTRUCTION OF A RISK INDEX FOR HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS
35. 43 POSTER Assessment of predictive biological markers with an oral angiogenic receptor tyrosine kinase (RTK) inhibitor, TSU-68, in the Phase I/II study for advanced hepatocellular carcinoma (HCC)
36. Final result of a phase I/II trial of the oral anti-angiogenesis inhibitor TSU-68 in patients with advanced hepatocellular carcinoma
37. MP-14.04: Evaluation of prostate cancer with real-time tissue elastography based on step-section pathologic analysis after radical prostatectomy
38. New feasibility study design with hepatocellular carcinoma: A phase I/II study of TSU-68, an oral angiogenesis inhibitor
39. Neoclassical reversed-field pinch equilibrium with dominant self-induced plasma current
40. Forefront of radiofrequency ablation treatment of hepatic cancer. 4. Therapeutic effect and long-term prognosis.
41. Extracellular Release of Recombinant α-Amylase from Escherichia coli Using Pulsed Electric Field
42. 2P183 Asymmetric nucleocytoplasmic transport using a novel in vitro assay system
43. 3P076 Statistical Analysis of Hydrogen Bonds in Protein Interior
44. Neoclassical MHD Equilibria in Low Aspect Ratio Reversed Field Pinch.
45. Thoracoscopic Thermal Ablation Therapy for Hepatocellular Carcinoma Located Beneath the Diaphragm
46. New Approach to Transport Improvement in a Helical Magnetic Axis System by Introduction of Effective Toroidal Curvature
47. Percutaneous hepatic infarction therapy for hepatocellular carcinoma.
48. Complete ablation of color doppler signals to evaluate response to treatment with percutaneous ethanol injection for hepatocellular carcinoma
49. Des-γ-carboxy prothrombin is the most important predisposing factor of portal vein tumor thrombus (PVTT) in hepatocellular carcinoma (HCC)
50. Percutaneous infarction therapy (PIT) for hepatocellular carcinoma (HCC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.